Sale!

CEBPA Mutation Detection Test

Original price was: $376.Current price is: $250.

-34%

The CEBPA Mutation Detection Test is a specialized genetic analysis that identifies mutations in the CCAAT/enhancer-binding protein alpha gene, which plays a critical role in normal blood cell development. This advanced molecular diagnostic test helps detect specific genetic abnormalities associated with acute myeloid leukemia (AML) and provides crucial information for diagnosis, prognosis, and treatment planning. By identifying CEBPA mutations, healthcare providers can better understand disease characteristics and guide personalized treatment approaches. The test is particularly valuable for patients with suspected or confirmed AML who may benefit from targeted therapies. With results available in 10 working days and a current discounted price of $250 USD, this test offers accessible genetic insights for improved leukemia management and patient outcomes.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CEBPA Mutation Detection Test: Advanced Genetic Analysis for Leukemia Diagnosis

Understanding CEBPA Mutation Detection

The CEBPA Mutation Detection Test represents a cutting-edge molecular diagnostic approach that examines the CCAAT/enhancer-binding protein alpha gene, a crucial transcription factor involved in normal hematopoiesis and myeloid differentiation. This specialized genetic analysis provides essential insights for patients with acute myeloid leukemia (AML), offering critical information that can significantly impact treatment decisions and prognostic assessments.

What Does the CEBPA Mutation Detection Test Measure?

This sophisticated molecular test specifically identifies mutations within the CEBPA gene, which encodes a transcription factor essential for proper granulocyte development and function. The test detects:

  • Point mutations affecting specific amino acid residues
  • Frameshift mutations disrupting protein structure
  • Insertion and deletion mutations altering gene function
  • Double mutations affecting both CEBPA alleles

Who Should Consider CEBPA Mutation Testing?

This genetic analysis is particularly recommended for individuals presenting with:

  • Newly diagnosed acute myeloid leukemia (AML)
  • Unexplained cytopenias with suspected myeloid disorders
  • Family history of hematological malignancies
  • Patients requiring comprehensive genetic profiling for treatment planning
  • Individuals with normal karyotype AML seeking additional prognostic markers

Clinical Symptoms and Indications

Patients experiencing symptoms such as unexplained fatigue, recurrent infections, easy bruising or bleeding, bone pain, or abnormal blood counts may benefit from CEBPA mutation analysis as part of their diagnostic evaluation.

Benefits of CEBPA Mutation Detection

Undergoing CEBPA mutation testing provides numerous advantages for both patients and healthcare providers:

  • Accurate Prognostic Information: CEBPA mutations are associated with favorable outcomes in AML patients
  • Treatment Guidance: Results help inform chemotherapy intensity and stem cell transplantation decisions
  • Personalized Medicine: Enables tailored treatment approaches based on genetic profile
  • Disease Monitoring: Provides baseline genetic information for future monitoring
  • Family Risk Assessment: Helps identify potential hereditary factors in leukemia development

Understanding Your Test Results

Your CEBPA Mutation Detection Test results will fall into one of several categories:

Positive for CEBPA Mutations

A positive result indicates the presence of mutations in the CEBPA gene, which typically correlates with a more favorable prognosis in AML patients. Your oncologist will discuss how this information impacts your treatment plan and long-term outlook.

Negative for CEBPA Mutations

A negative result means no detectable mutations were found in the CEBPA gene. This information helps exclude this specific genetic abnormality and may guide further diagnostic testing to identify other relevant mutations.

Variant of Uncertain Significance

In some cases, the test may identify genetic changes whose clinical significance is not yet fully understood. Your healthcare provider will discuss the implications and any recommended follow-up testing.

Test Pricing and Availability

Test Name Discount Price Regular Price
CEBPA Mutation Detection Test $250 USD $376 USD

Testing Process and Timeline

Our advanced testing process ensures accurate and reliable results:

  • Sample Collection: 4 mL whole blood in EDTA tube (ship refrigerated)
  • Turnaround Time: 10 working days from sample receipt
  • Methodology: Advanced PCR-based detection
  • Sample Requirements: Daily acceptance by 11 AM

Nationwide Testing Availability

We proudly offer CEBPA Mutation Detection testing across the United States with convenient locations in major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures accessible testing for patients nationwide.

Take Control of Your Health Today

Don’t wait to get the critical genetic information you need for informed leukemia management. Our experienced team is ready to assist you with scheduling your CEBPA Mutation Detection Test and answering any questions about the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to book your test and take the first step toward personalized leukemia care.

Our dedicated patient coordinators are available to help you understand the testing process, discuss insurance coverage options, and schedule your appointment at a convenient location near you. With our discounted pricing and comprehensive genetic analysis, you can access the advanced diagnostic information needed for optimal leukemia management.